Literature DB >> 2465287

A gag-env hybrid protein of human T-cell leukemia virus type I and its application to serum diagnosis.

T Kuga1, M Yamasaki, S Sekine, M Fukui, Y Yokoo, S Itoh, M Yoshida, T Hattori, K Takatsuki.   

Abstract

A fused gene of the gag and env sequences of human T-cell leukemia virus type I (HTLV-I), the causative agent of adult T-cell leukemia, was constructed in vitro and expressed in Escherichia coli. The gag-env hybrid protein accumulated as insoluble granules with a yield of approximately 12% of the total proteins. In an enzyme-linked immunosorbent assay done with the use of the gag-env hybrid protein, all 57 seropositive sera gave positive signals, and none of the sera from normal persons did. This system can produce large quantities of the gag-env hybrid protein, which can be used for mass screening of human sera for HTLV-I infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2465287      PMCID: PMC5917652          DOI: 10.1111/j.1349-7006.1988.tb01541.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

2.  Cloning and expression of cDNA for salmon growth hormone in Escherichia coli.

Authors:  S Sekine; T Mizukami; T Nishi; Y Kuwana; A Saito; M Sato; S Itoh; H Kawauchi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

3.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

Authors:  M Yoshida; M Seiki; K Yamaguchi; K Takatsuki
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients.

Authors:  K Okochi; H Sato; Y Hinuma
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

5.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  A plasmid vector for cloning and expression of gene segments: expression of an HTLV-I envelope gene segment.

Authors:  W P Sisk; J G Chirikjian; J Lautenberger; C Jorcyk; T S Papas; M L Berman; R Zagursky; D L Court
Journal:  Gene       Date:  1986       Impact factor: 3.688

7.  A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors:  M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal:  Gan       Date:  1984-10

8.  Expression of the gag gene of human T-cell leukemia virus type I in Escherichia coli and its diagnostic use.

Authors:  S Itamura; K Shigesada; M Imai; N Kobayashi; T Hamakado; T Harada; M Hatanaka
Journal:  Gene       Date:  1985       Impact factor: 3.688

9.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  4 in total

1.  Novel Genetic Constructs for Production of Recombinant HTLV-1/2 Antigens and Evaluation of Their Reactivity to Plasma Samples from HTLV-1-Infected Patients.

Authors:  Ueriton Dias de Oliveira; Fred Luciano Neves Santos; Bernardo Galvão-Castro; Marco Aurelio Krieger; Nilson Ivo Tonin Zanchin
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

2.  Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.

Authors:  H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki
Journal:  J Clin Immunol       Date:  1991-05       Impact factor: 8.317

3.  Antigenic cross-reactivity between human T lymphotropic virus type I (HTLV-I) and retinal antigens recognized by T cells.

Authors:  A Fukushima; H Ueno; S Fujimoto
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

4.  Chemiluminescence immunoassay to detect anti-HTLV-I antibodies.

Authors:  S Kamihira; S Nakashima; S Saitoh; M Kawamoto; Y Kawashima; M Shimamoto
Journal:  Jpn J Cancer Res       Date:  1993-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.